Abstract
Medicare does not reimburse for home infusion; patients requiring outpatient parenteral antimicrobial therapy must seek treatment in high-risk settings. We recommend policy change to allow for adequate social distancing during the coronavirus disease 2019 pandemic.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3250-3251 |
| Number of pages | 2 |
| Journal | Clinical Infectious Diseases |
| Volume | 71 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 15 2020 |
Keywords
- CMS
- COVID-19
- Health Insurance Policy
- OPAT
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics Amidst a Pandemic'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS